Advaxis is a biotechnology business based in the US. Advaxis shares (ADXS) are listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and all prices are listed in US Dollars. Its last market close was $0.03 – the same closing value as a week prior. Advaxis employs 20 staff and has a trailing 12-month revenue of around $13,000.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.03 |
|---|---|
| 52-week range | $0.00 - $1.49 |
| 50-day moving average | $0.05 |
| 200-day moving average | $0.28 |
| Wall St. target price | $4.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-7.99 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.027 from 2024-12-05
| 1 week (2024-11-29) | 0.027 |
|---|---|
| 1 month (2024-11-07) | 0.027 |
| 3 months (2024-09-06) | 35.00% |
| 6 months (2024-06-06) | -90.00% |
| 1 year (2023-12-06) | -96.61% |
|---|---|
| 2 years (2022-12-07) | -98.20% |
| 3 years (2021-12-07) | 28.352 |
| 5 years (2019-12-06) | 61.36 |
| Revenue TTM | $13,000 |
|---|---|
| Gross profit TTM | $0 |
| Return on assets TTM | -181.05% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $-2.05 |
| Market Capitalization | $1.2 million |
TTM: trailing 12 months
We're not expecting Advaxis to pay a dividend over the next 12 months.
Advaxis's shares were split on a 1:80 basis on 5 June 2022 . So if you had owned 80 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Advaxis shares – just the quantity. However, indirectly, the new 7900% higher share price could have impacted the market appetite for Advaxis shares which in turn could have impacted Advaxis's share price.
Ayala Pharmaceuticals, Inc. , a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware. .
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Our star ratings for online brokerages are based on how they stack up in nine key categories.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.